Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.00
Bid: 40.00
Ask: 42.00
Change: 0.00 (0.00%)
Spread: 2.00 (5.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 41.00
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pulsiv announces £1.5m fundraise

8 Nov 2022 07:00

RNS Number : 5979F
Frontier IP Group plc
08 November 2022
 

Reach - a non-regulatory announcement

AIM: FIPP

08 November 2022

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

 

Portfolio news - Pulsiv announces £1.5 million equity funding round

 

Frontier IP, a specialist in commercialising intellectual property, today welcomes the following announcement from portfolio company Pulsiv Limited (or the "Company") that it has completed a £1.5 million fundraising through an equity funding round with new and existing investors to develop and scale up its energy-efficient power conversion technology.

 

The fundraising values Pulsiv at £50 million pre money. Frontier IP invested £273,000, and holds an 18.3 per cent equity stake in the Company following this.

 

As previously announced by the Group, Pulsiv completed a first closing of its fundraising in July 2022. The increase in the fair value of the Group's holding in Pulsiv as a result of the fundraising was reflected in Frontier IP's audited final results which were released on 27 October 2022.

 

Pulsiv believes its groundbreaking technology significantly improves the energy efficiency of power supplies, battery chargers and LED lighting, and extracts much more energy from photovoltaic solar cells. Because it uses fewer components, it can be incorporated into more compact designs and is cost effective for manufacturers.

 

The Company has made strong commercial progress. It has recently announced a collaboration with Salom Europe, a leading manufacturer of power supplies for consumer electronics. Pulsiv has also signed strategic distribution agreements with Digikey, the world's fifth largest electronic components distributor, and Astute Electronics, which will promote the technology to manufacturers in the UK, Germany, Israel, Turkey and Australia. The Company has also announced a pan-European representative agreement with ISMOsys Group, part of Astute.

 

 

Neil Crabb, Frontier IP Chief Executive Officer, said: "We believe Pulsiv will become a major green company. Converting power more efficiently means less energy is wasted, so the technology has the potential to cut carbon emissions, reduce strain on national power grids and cut energy bills for consumers. We are delighted with the results of this funding round. "

 

Pulsiv statement begins:

 

 

Pulsiv raises £1.5m in latest funding round

Cambridge 08 November 2022

Pulsiv Limited ("Pulsiv"), a UK-based cleantech company announces that it has raised £1.5m through an equity funding round supported by existing shareholders, including management and Frontier IP Group plc (a founder of the business), and new angel investors. The round remains open.

Pulsiv's unique technology aims to conserve every watt of power that needs converting when consumer devices are run from a mains supply, when batteries are being charged, when LED lights are illuminated or when electricity is generated from solar panels. 

Products under the Pulsiv OSMIUM brand are designed for always-efficient power supplies. Pulsiv HORIZON technology has been developed for advanced solar micro-inverters and power optimizers. The company sells a range of system controllers that intelligently manage power conversion. Our proven reference designs will enable seamless integration by OEMs and accelerate industry adoption.

The Pulsiv OSMIUM architecture can be used in a broad range of OEM products that demand high efficiency, compact design and a low-cost bill of materials. Pulsiv OSMIUM technology exceeds the highest Energy Star standards, eliminates inrush current, reduces overall component cost/count and delivers consistent performance from no-load through to full power. Our scalable solution promotes a platform approach and economies of scale - most components remain unchanged across different designs.

Pulsiv HORIZON employs patented methods for extracting more energy from solar panels than alternative solutions, and our innovative prototype uses a unique split architecture to maximize the power generated by solar micro-inverters and power optimizers under all operating conditions. Standard reference designs will create greater competition, ensuring that future solar installations will generate maximum returns and accelerate the transition towards renewable energy.

The investment raised during this round supports the commercialization of Pulsiv OSMIUM and the ongoing development of Pulsiv HORIZON:

- Pulsiv OSMIUM development systems are currently being manufactured to support customer evaluations and product integration.

- Pulsiv OSMIUM reference designs will simplify the customer journey and drive mass-market adoption. 

- Pulsiv HORIZON reference designs will demonstrate our new architecture for power optimiser and microinverters with best-on-class CEC/EU efficiency and power delivery.

Pulsiv's original concept for more efficient power conversion between AC and DC was developed by Zaki Ahmed and spun-out of the University of Plymouth. It is protected through multiple patent families and trademarks.

A global energy transition is underway to phase out fossil fuels and reduce greenhouse gas emissions. IRENA (International Renewal Energy Agency) reports that 90% of the required carbon reductions can be achieved by switching to renewable energy sources and implementing a range of efficiency measures. Rising energy prices, concerns about energy security and inflationary pressures are also driving the need for Pulsiv technology. 

Pulsiv CEO Darrel Kingham commented: 

"We are delighted to have secured this funding given the challenging fundraising environment and full credit goes to my leadership team and our strategic partners. This shows confidence in our progress over the last 18 months, with Pulsiv OSMIUM far exceeding the original design goals and the Pulsiv HORIZON prototype producing best-in-class results. The many benefits of our technology will challenge conventional thinking and give customers an opportunity to differentiate their products in a number of markets."

 

Pulsiv statement ends

 

 

 

 

 

 

 

 

 

 

ENQUIRIES

 

 

Frontier IP Group Plc

T: 020 7332 2338

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

Company website: www.frontierip.co.uk

neil@frontierip.co.uk

M: 07464 546 025

Allenby Capital Limited (Nominated Adviser)

Nick Athanas / George Payne

 

T: 0203 328 5656

 

 

 

ABOUt pulsiv

Pulsiv's unique technology is enabling the electronics industry to create innovative power supply designs and best-in-class solar solutions. Using patented techniques, our intelligent controllers and supporting reference designs improve efficiency, optimize cost and maximize system performance.We're helping the global transition to renewable energy and improving power consumption for a more sustainable future. 

ABout frontier IP

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

About Reach announcements

This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEANFXESLAFFA
Date   Source Headline
2nd May 20247:00 amRNSFrontier IP announces stake in DiaGen
17th Apr 20241:59 pmRNSHolding(s) in Company
12th Apr 20247:00 amRNSAppointment of Chief Financial Officer
2nd Apr 202412:44 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSUnaudited Half Year Results
4th Mar 20241:40 pmRNSHolding(s) in Company
29th Feb 20243:12 pmRNSSale of shares in Exscientia
30th Jan 202411:45 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSOctopus invest in Alusid as part of equity funding
29th Dec 202312:00 pmRNSTotal Voting Rights
19th Dec 20234:46 pmRNSHolding(s) in Company
15th Dec 20236:12 pmRNSReplacement - Result of AGM and Directorate Change
15th Dec 20232:07 pmRNSResult of AGM and Directorate Change
13th Dec 20237:00 amRNSPortfolio news - The Vaccine Group
11th Dec 20237:00 amRNSHolding(s) in Company
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholdings
28th Nov 20237:00 amRNSBoard Change
21st Nov 20237:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20235:27 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSGrant of options
1st Nov 20235:48 pmRNSExercise of Options & PDMR Shareholdings & TVR
31st Oct 20237:01 amRNSBoard changes
31st Oct 20237:00 amRNSFinal results for the year ended 30 June 2023
23rd Oct 20237:00 amRNSNew portfolio company Deakin Bio-Hybrid Materials
12th Oct 20232:05 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSExscientia announces collaboration with Merck
14th Sep 20235:21 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
11th Sep 20237:00 amRNSPortfolio news – Pulsiv appoints Chairman and CPO
8th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
10th Aug 20238:45 amRNSPortfolio news – Fieldwork Robotics
24th Jul 20237:00 amRNSPortfolio news – CamGraPhIC loan facility
20th Jul 20235:18 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSSale of shares in Exscientia
26th May 20236:06 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTopps Tiles launches first Alusid made tile range
21st Apr 20234:00 pmRNSDirectorate Change
20th Apr 20235:26 pmRNSHolding(s) in Company
27th Mar 20235:17 pmRNSHolding(s) in Company
17th Mar 20232:46 pmRNSGrant of options
15th Mar 20237:00 amRNSBoard changes
15th Mar 20237:00 amRNSUnaudited Half Year Results
30th Jan 20237:00 amRNSAlusid in collaboration with Imerys
9th Jan 20237:00 amRNSCelerum appoints David Gladding as CEO
9th Dec 20224:08 pmRNSResult of AGM
7th Dec 20221:25 pmEQSThe Vaccine Group completes two deadly disease vaccination projects
6th Dec 20227:00 amRNSFrontier IP to host Portfolio Demo Day
5th Dec 20227:00 amRNSThe Vaccine Group completes Lassa fever project
2nd Dec 20227:00 amRNSThe Vaccine Group completes vaccine project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.